We are live on
!
Find out more
MWNA
Marshall Wace North America Portfolio holdings
AUM
$23.5B
1-Year Est. Return
46.46%
This Fund
S&P 500
This Quarter
Est. Return
+7.23%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$17.7B
AUM Growth
-$2.27B
(-11%)
Cap. Flow
-$3.05B
Cap. Flow
% of AUM
-17.25%
Top 10 Holdings %
Top 10 Hldgs %
15.77%
Holding
1,947
New
557
Increased
335
Reduced
444
Closed
606
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$113M |
| 2 |
BERY
Berry Global Group, Inc.
BERY
|
+$106M |
| 3 |
Merck
MRK
|
+$95.9M |
| 4 |
Baidu
BIDU
|
+$85.8M |
| 5 |
IQVIA
IQV
|
+$83.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$229M |
| 2 |
Las Vegas Sands
LVS
|
+$150M |
| 3 |
Alibaba
BABA
|
+$131M |
| 4 |
Citigroup
C
|
+$130M |
| 5 |
Micron Technology
MU
|
+$105M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.85% |
| 2 | Technology | 15.39% |
| 3 | Consumer Discretionary | 13.45% |
| 4 | Industrials | 10.48% |
| 5 | Financials | 9.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Quanta Services
PWR
$100B
| $24.5M | 0.14% |
733,782
+297,670
| +68% | +$10.4M |
|
|
XL
177
DELISTED
XL Group Ltd.
XL
| $24.4M | 0.14% |
435,401
-1,825,581
| -81% | -$102M |
|
178
Rithm Capital
RITM
$5.55B
| $24.2M | 0.14% |
+1,385,979
| New | +$24.3M |
|
179
Exelixis
EXEL
$13.1B
| $23.9M | 0.13% |
1,109,202
-691,130
| -38% | -$14.3M |
|
|
LSXMA
180
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $23.7M | 0.13% |
726,945
+149,779
| +26% | +$4.75M |
|
181
Martin Marietta Materials
MLM
$32.3B
| $23.5M | 0.13% |
+105,249
| New | +$22.5M |
|
|
AKRX
182
CALL
DELISTED
Akorn Inc
AKRX
| $23.4M | 0.13% |
+1,250,000
| New | +$19.2M |
|
183
Melco Resorts & Entertainment
MLCO
$2.14B
| $23.4M | 0.13% |
835,098
-123,705
| -13% | -$3.79M |
|
184
Owens Corning
OC
$12.1B
| $23.3M | 0.13% |
367,431
+250,616
| +215% | +$17.3M |
|
185
Qiagen
QGEN
$8.61B
| $23.2M | 0.13% |
604,796
-329,233
| -35% | -$12.1M |
|
186
DuPont de Nemours
DD
$19.5B
| $23.1M | 0.13% |
138,112
-16,227
| -11% | -$2.72M |
|
|
PINC
187
DELISTED
Premier
PINC
| $23M | 0.13% |
+632,544
| New | +$21M |
|
|
188
Johnson & Johnson
JNJ
$619B
| $22.8M | 0.13% |
188,093
-1,838,105
| -91% | -$229M |
|
189
Greif
GEF
$5.07B
| $22.6M | 0.13% |
427,932
-33,132
| -7% | -$1.91M |
|
190
Bloomin' Brands
BLMN
$931M
| $22.6M | 0.13% |
1,122,484
+792,430
| +240% | +$18M |
|
191
Intuitive Surgical
ISRG
$132B
| $22.4M | 0.13% |
140,130
+16,296
| +13% | +$2.49M |
|
|
EQC
192
DELISTED
Equity Commonwealth
EQC
| $22.2M | 0.13% |
+704,280
| New | +$21.8M |
|
193
Weibo
WB
$1.94B
| $22.1M | 0.12% |
249,035
+237,097
| +1,986% | +$25.8M |
|
|
WGL
194
DELISTED
Wgl Holdings
WGL
| $21.9M | 0.12% |
+246,263
| New | +$21.4M |
|
195
Altria Group
MO
$113B
| $21.8M | 0.12% |
+384,468
| New | +$22.2M |
|
196
Halliburton
HAL
$27.1B
| $21M | 0.12% |
467,023
+382,540
| +453% | +$19.1M |
|
|
AYX
197
DELISTED
Alteryx Inc
AYX
| $21M | 0.12% |
+549,459
| New | +$19.2M |
|
198
Marvell Technology
MRVL
$189B
| $20.3M | 0.11% |
946,685
-4,169,964
| -81% | -$89M |
|
199
ABM Industries
ABM
$2.84B
| $20.3M | 0.11% |
694,467
+3,253
| +0.5% | +$100K |
|
|
FSCT
200
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
| $20.1M | 0.11% |
587,360
+285,218
| +94% | +$9.27M |
|
Similar funds
TGHSA
PAM
HB
MWA
3SCA
HFCIV
DVC
NAM
Marshall Wace North America's Q2 2018 Portfolio in Review
As of Q2 2018, Marshall Wace North America held 1,947 positions worth $17.7B, down 11% from $20B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Marshall Wace North America withdrew a net $3.05B in Q2 2018, closing 606 positions and reducing 444 holdings. Its most notable exit was Time Warner Inc, an estimated $63.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Marshall Wace North America opened a new position in IQVIA worth $83.1M.
- Marshall Wace North America's largest Q2 2018 buy was IQVIA: 832,159 shares worth $83.1M.
- Marshall Wace North America added most to Vertex Pharmaceuticals in Q2 2018, an estimated $113M increase.
- Marshall Wace North America's biggest Q2 2018 reduction was Johnson & Johnson, cutting an estimated $229M.
- Marshall Wace North America fully exited Time Warner Inc in Q2 2018, selling an estimated $63.3M.
- Marshall Wace North America's ten largest holdings make up 16% of its $17.7B portfolio in Q2 2018.
- Marshall Wace North America opened 557 new positions and closed 606 in Q2 2018.
- Marshall Wace North America's portfolio value fell 11% quarter-over-quarter to $17.7B.
Based on Marshall Wace North America's 13F filing for Q2 2018, filed 14 Aug 2018.